BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
5 results:

  • 1. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The cancer Genome Atlas-like Prognostic Subgroups.
    Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
    Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A prospective study on the predictive value of DNA methylation in cervical intraepithelial neoplasia prognosis.
    Guo Z; Hu Y; Yuan L; Li N; Wang T
    Arch Gynecol Obstet; 2018 Sep; 298(3):589-596. PubMed ID: 29971561
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
    Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. uterine adenosarcomas are mesenchymal neoplasms.
    Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
    J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Heterogeneity of tert promoter mutations status in squamous cell carcinomas of different anatomical sites.
    Cheng KA; Kurtis B; Babayeva S; Zhuge J; Tantchou I; Cai D; Lafaro RJ; Fallon JT; Zhong M
    Ann Diagn Pathol; 2015 Jun; 19(3):146-8. PubMed ID: 25862495
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.